Phase I neutralization study of EP 217609 and its antidote avidin in volunteers.

Trial Profile

Phase I neutralization study of EP 217609 and its antidote avidin in volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 15 Oct 2016

At a glance

  • Drugs Avidin (Primary) ; EP 217609 (Primary)
  • Indications Thrombosis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 15 Oct 2016 Results published in the European Journal of Clinical Pharmacology
    • 07 Mar 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top